In this study, we aimed to reveal whether the MCM6 expression score can be interpreted as a proliferative marker and be used as an alternative to Ki-67 in differentiating molecular subtypes and also histologic grades of breast cancer. This evidence concerns the gene MKI67 and breast cancer.